Private Equity

JPMorgan’s Dimon signals PE firms likely to struggle in a bear market

The bank CEO expressed surprise at the lack of listings by PE-owned businesses in the past year, when public markets were at all-time highs.
JP Morgan CEO Jamie Dimon

JPMorgan CEO Jamie Dimon

Kevin Dietsch/Getty Images

Jamie Dimon has flagged private equity’s current predicament—holding periods nearly doubling, IPOs underwhelming and continuation funds proliferating—and posed an uncomfortable question: What happens when the good times end?

In his annual letter to shareholders, the chairman and chief executive of JPMorgan Chase said he was surprised that PE firms “have not taken greater advantage of healthy markets to take their companies public,” noting that stock markets have hit all-time highs in recent months.

The average hold period for a PE investment is “virtually double what it used to be,” at seven years, he added, with more companies being rolled into continuation funds rather than sold or listed.

At a structural level, PE firms have struggled with a persistent spread between the valuations they assign to their portfolio companies and what stock market investors are willing to pay at IPO, according to the think tank Center for Economic and Policy Research, among others.

“We have generally had nothing but a bull market since the great financial crisis—it’s hard to imagine what will happen [to the PE market] if and when we have an extended bear market,” he said.

In 2025, there were 180 PE-backed IPOs globally totaling $311 billion, a considerable step up from 2024, when there were 167 listings worth $171 billion, according to PitchBook data.

Volumes in dollar terms were driven by a handful of very large deals, such as the December listing of Medline. The medical supply company raised $6.3 billion in an upsized offering that gave the business—backed by The Carlyle Group, Blackstone and Hellman & Friedman—a pre-money valuation of $31.8 billion. The first quarter of 2025 also saw the listing of Venture Global LNG, in a deal valuing the energy producer at $58.7 billion.

By deal count, however, 2025 lagged the pre-pandemic average of 229 listings per year.

“Investors are still tentative and want to see more IPO successes before they test the markets with their portfolio companies,” said Jinny Choi, senior PE analyst at PitchBook. The government shutdown in the second half of last year was a further setback for the IPO market, she added.

For every success such as Medline, which saw its share price pop by 41% on its first day of trading and has continued to climb since, there are companies like Thoma Bravo-backed SailPoint—whose share price fell below the IPO price on day one of trading in February last year, despite being heavily oversubscribed. Shares in the security and governance software company, which listed at a valuation of $12.8 billion, are trading down around 61% below their IPO price today.

A spokeswoman for JPMorgan declined to elaborate further on the reasons behind the relative lack of PE-backed IPOs.

Elsewhere in the letter, Dimon said the problems in private credit are unlikely to represent a systemic risk. Losses on all leveraged lending will be higher than expected, though, due to weakening credit standards, he said.

Overly positive assumptions about future performance, weaker covenants in loan agreements, and an increase in payment-in-kind are among the factors he cited, along with a lack of transparency about how loans are valued.

“This [opacity] increases the chance that people will sell if they think the environment will get worse, even if actual realized losses barely change,” he said.

Learn about our editorial standards.